Current and Emerging Therapeutic Strategies for the Treatment of Meibomian Gland Dysfunction (MGD)
- PMID: 26130187
- DOI: 10.1007/s40265-015-0432-8
Current and Emerging Therapeutic Strategies for the Treatment of Meibomian Gland Dysfunction (MGD)
Abstract
Meibomian gland (MG) dysfunction (MGD) is a multifactorial, chronic condition of the eyelids, leading to eye irritation, inflammation and ocular surface disease. Initial conservative therapy often includes a combination of warm compresses in addition to baby shampoo or eyelid wipes. The practice of lid hygiene dates back to the 1950s, when selenium sulfide-based shampoo was first used to treat seborrhoeic dermatitis of the eyelids. Today, tear-free baby shampoo has replaced dandruff shampoo for MGD treatment and offers symptom relief in selected patients. However, many will not achieve significant improvement on this therapy alone; some may even develop an allergy to the added dyes and fragrances in these products. Other manual and mechanical techniques to treat MGD include MG expression and massage, MG probing and LipiFlow(®). While potentially effective in patients with moderate MGD, these procedures are more invasive and may be cost prohibitive. Pharmacological treatments are another course of action. Supplements rich in omega-3 fatty acids have been shown to improve both MGD and dry eye symptoms. Tea tree oil, specifically the terpenin-4-ol component, is especially effective in treating MGD associated with Demodex mites. Topical antibiotics, such as azithromycin, or systemic antibiotics, such as doxycycline or azithromycin, can improve MGD symptoms both by altering the ocular flora and through anti-inflammatory mechanisms. Addressing and treating concurrent ocular allergy is integral to symptom management. Topical N-acetylcysteine and topical cyclosporine can both be effective therapeutic adjuncts in patients with concurrent dry eye. A short course of topical steroid may be used in some severe cases, with monitoring for steroid-induced glaucoma and cataracts. While the standard method to treat MGD is simply warm compresses and baby shampoo, a more tailored approach to address the multiple aetiologies of the disease is suggested.
Similar articles
-
Mechanical meibomian gland squeezing combined with eyelid scrubs and warm compresses for the treatment of meibomian gland dysfunction.Clin Exp Optom. 2017 Nov;100(6):598-602. doi: 10.1111/cxo.12532. Epub 2017 Mar 12. Clin Exp Optom. 2017. PMID: 28295626
-
Evaluation of an automated thermodynamic treatment (LipiFlow®) system for meibomian gland dysfunction: a prospective, randomized, observer-masked trial.Ocul Surf. 2014 Apr;12(2):146-54. doi: 10.1016/j.jtos.2013.12.001. Epub 2014 Jan 22. Ocul Surf. 2014. PMID: 24725326 Clinical Trial.
-
[Modern approaches to the treatment of meibomian gland dysfunction].Vestn Oftalmol. 2021;137(1):130-136. doi: 10.17116/oftalma2021137011130. Vestn Oftalmol. 2021. PMID: 33610161 Russian.
-
Emerging treatment options for meibomian gland dysfunction.Clin Ophthalmol. 2013;7:1797-803. doi: 10.2147/OPTH.S33182. Epub 2013 Sep 9. Clin Ophthalmol. 2013. PMID: 24043929 Free PMC article. Review.
-
Meibomian Gland Disease: The Role of Gland Dysfunction in Dry Eye Disease.Ophthalmology. 2017 Nov;124(11S):S20-S26. doi: 10.1016/j.ophtha.2017.05.031. Ophthalmology. 2017. PMID: 29055358 Free PMC article. Review.
Cited by
-
Compliance and Subjective Patient Responses to Eyelid Hygiene.Eye Contact Lens. 2017 Jul;43(4):213-217. doi: 10.1097/ICL.0000000000000258. Eye Contact Lens. 2017. PMID: 27243349 Free PMC article.
-
Ocular Myasthenia Gravis with Severe Blepharitis and Ocular Surface Disease: A Case Report.Case Rep Ophthalmol. 2020 Jul 13;11(2):322-329. doi: 10.1159/000508815. eCollection 2020 May-Aug. Case Rep Ophthalmol. 2020. PMID: 32884545 Free PMC article.
-
Eyelid margin cleaning using Deep Cleaning Device for the treatment of meibomian gland dysfunction-associated dry eye: a preliminary investigation.J Zhejiang Univ Sci B. 2019 Aug.;20(8):679-686. doi: 10.1631/jzus.B1900091. J Zhejiang Univ Sci B. 2019. PMID: 31273965 Free PMC article. Clinical Trial.
-
Advances in dry eye disease treatment.Curr Opin Ophthalmol. 2019 May;30(3):166-178. doi: 10.1097/ICU.0000000000000569. Curr Opin Ophthalmol. 2019. PMID: 30883442 Free PMC article. Review.
-
The Predictive Potential of Altered Voxel-Based Morphometry in Severely Obese Patients With Meibomian Gland Dysfunction.Front Neurosci. 2022 Jul 7;16:939268. doi: 10.3389/fnins.2022.939268. eCollection 2022. Front Neurosci. 2022. PMID: 35873814 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical